Teleflex (TFX) Tops Q2 EPS by 20c
Tweet
Share
E-mailGet Alerts TFX Hot Sheet
Price: $136.32 --0%
Financial Fact:
Research and development expenses: 15.07M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development expenses: 15.07M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Teleflex (NYSE: TFX) reported Q2 EPS of $3.41, $0.20 better than the analyst estimate of $3.21. Revenue for the quarter came in at $743.3 million versus the consensus estimate of $729.88 million.
For earnings history and earnings-related data on Teleflex (TFX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
